Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/CHEBI_72312
http://purl.obolibrary.org/obo/CHEBI_72312
|
|---|---|
| Preferred Name | pasireotide |
| Synonyms |
pasireotida
pasireotide
SOM 230
cyclo((4R)-4-(2-aminoethylcarbamoyloxy)-L-prolyl-L-phenylglycyl-D-tryptophyl-L-lysyl-4-O-benzyl-L-tyrosyl-L- phenylalanyl-)
SOM230
C58H66N10O9
cyclo[(2S)-2-phenylglycyl-D-tryptophyl-L-lysyl-O-benzyl-L-tyrosyl-L-phenylalanyl-(4R)-4-{[(2-aminoethyl)carbamoyl]oxy}-L-prolyl]
SOM-230
pasireotidum
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | pasireotide
|
|---|---|
| label | pasireotide
|
| DBSynonym | som230
|
| ATCCode | H01CB05
|
| Definition | A six-membered homodetic cyclic peptide composed from L-phenylglycyl, D-tryptophyl, L-lysyl, O-benzyl-L-tyrosyl, L-phenylalanyl and modified L-hydroxyproline residues joined in sequence. A somatostatin analogue with pharmacologic properties mimicking those of the natural hormone somatostatin; used (as its diaspartate salt) for treatment of Cushing's disease.
Pasireotide is a synthetic long-acting cyclic hexapeptide with somatostatin-like activity. It is marketed as a diaspartate salt called Signifor?, which is used in the treatment of Cushing s disease.
|
| DBSalt | pasireotide diaspartate
|
| type | |
| has role | |
| InChIKey | InChIKey=VMZMNAABQBOLAK-DBILLSOUSA-N
|
| Synonym | pasireotida
pasireotide
SOM 230
cyclo((4R)-4-(2-aminoethylcarbamoyloxy)-L-prolyl-L-phenylglycyl-D-tryptophyl-L-lysyl-4-O-benzyl-L-tyrosyl-L- phenylalanyl-)
SOM230
C58H66N10O9
cyclo[(2S)-2-phenylglycyl-D-tryptophyl-L-lysyl-O-benzyl-L-tyrosyl-L-phenylalanyl-(4R)-4-{[(2-aminoethyl)carbamoyl]oxy}-L-prolyl]
SOM-230
pasireotidum
See more
See less
|
| xref |
KEGG DRUG:D10147
CiteXplore:22383336
CiteXplore:21493671
Wikipedia:http://en.wikipedia.org/wiki/Pasireotide
CiteXplore:22634958
CiteXplore:21732759
CiteXplore:23137853
RxList:http://www.rxlist.com/signifor-drug.htm
CiteXplore:22736724
CiteXplore:22807497
Wikipedia:Pasireotide
CiteXplore:20643121
CiteXplore:22745760
CiteXplore:20970474
CiteXplore:22713526
CiteXplore:22965070
CiteXplore:21506098
CiteXplore:21330405
CiteXplore:21532334
CiteXplore:23345100
CiteXplore:21525729
CiteXplore:23102680
Reaxys:9469122
CiteXplore:21673137
CiteXplore:22282526
Drugs.com:http://www.drugs.com/signifor.html
ChEBI:72312
CiteXplore:22170729
CiteXplore:22960304
CiteXplore:22573933
CiteXplore:21264796
CASRN:396091-73-9
See more
See less
|
| CASRN | 396091-73-9
|
| prefixIRI | obo2:CHEBI_72312
|
| related with | |
| SMILES | NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O)OC(=O)NCCN)c1ccccc1
|
| may interact with | |
| InChI | InChI=1S/C58H66N10O9/c59-27-13-12-22-46-52(69)64-47(30-38-23-25-42(26-24-38)76-36-39-16-6-2-7-17-39)53(70)66-49(31-37-14-4-1-5-15-37)57(74)68-35-43(77-58(75)61-29-28-60)33-50(68)55(72)67-51(40-18-8-3-9-19-40)56(73)65-48(54(71)63-46)32-41-34-62-45-21-11-10-20-44(41)45/h1-11,14-21,23-26,34,43,46-51,62H,12-13,22,27-33,35-36,59-60H2,(H,61,75)(H,63,71)(H,64,69)(H,65,73)(H,66,70)(H,67,72)/t43-,46+,47+,48-,49+,50+,51+/m1/s1
|
| DBBrand | signifor?
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |